- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07813676
Effect of Digital-Supported Foot Care Education in Individuals With Type 2 Diabetes
4. september 2026 opdateret af: Zeliha Buyukbayram Genç, Siirt University
The Effect of Digital-Supported Foot Care Education on Knowledge, Self-Care Behavior, and Self-Efficacy in Individuals With Type 2 Diabetes: A Randomized Controlled Trial
This randomized controlled trial will evaluate the effect of digital-supported foot care education on foot care knowledge, self-care behaviors, and self-efficacy in individuals with type 2 diabetes.
A total of 90 participants will be randomly assigned to an intervention group (n=45) or a control group (n=45).
Participants in the intervention group will receive structured foot care education supported by videos and visual materials accessible through QR codes, together with hands-on training using a diabetic foot model.
Participants in the control group will receive standard care.
Foot care knowledge, self-care behaviors, and foot care self-efficacy will be assessed before and after the intervention.
The study aims to determine whether digital-supported foot care education is effective in improving these outcomes among individuals with type 2 diabetes.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
90
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Zeliha Buyukbayram Genç, PhD
- Telefonnummer: +905533931157
- E-mail: zeliha_bbayram@hotmail.com
Studiesteder
-
-
Siirt
-
Siirt, Siirt, Tyrkiet (Türkiye), 56100
- Siirt Training and Research Hospital
-
Kontakt:
- Zeliha Buyukbayram Genç, PhD
- Telefonnummer: +905533931157
- E-mail: zeliha_bbayram@hotmail.com
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Diagnosis of type 2 diabetes mellitus according to ICD-10 criteria for at least 6 months.
- Age 18 years or older.
- Stable general health condition.
- No condition that would prevent communication or understanding of the education, including severe cognitive, hearing, or speech impairment.
- Ability to communicate in Turkish and sufficient cognitive ability to understand the education.
- Voluntary participation and provision of written informed consent.
- Ability to access video and visual educational materials via QR codes either independently or with the assistance of a relative/caregiver.
Exclusion Criteria:
- Previous participation in a structured diabetic foot care education program.
- Presence of an active diabetic foot ulcer or a history of amputation.
- Presence of a serious neurological or orthopedic condition, other than diabetes-related conditions, that may directly affect foot care.
- Anticipated inability to regularly participate in the planned education and follow-up procedures.
- Presence of an acute complication of diabetes requiring emergency clinical intervention.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Digital-Supported Foot Care Education Group
Participants assigned to the intervention group will receive two individual face-to-face foot care education sessions, each lasting 20-25 minutes.
The education will be supported by QR code-accessible video and visual materials and hands-on demonstrations using a diabetic foot model.
Participants will be encouraged to access the digital materials at least twice a week for four weeks and will receive regular reminders via text messages and/or telephone calls.
|
Participants will receive two individual face-to-face foot care education sessions, each lasting 20-25 minutes.
The education will include practical demonstrations using a diabetic foot model and will be supported by video and visual materials accessible via QR codes.
Participants will be encouraged to access the digital materials at least twice a week for four weeks.
During this period, regular reminders will be provided via text messages and/or telephone calls to support continued engagement with the educational materials.
|
|
Ingen indgriben: Control Group
Participants assigned to the control group will continue to receive routine care and will not receive the digital-supported foot care education during the study period.
After completion of the study, the educational materials will be offered to control group participants who wish to receive them.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Diabetic Foot Care Knowledge
Tidsramme: Baseline and at the end of Week 4
|
Diabetic foot care knowledge will be assessed using the Diabetic Foot Knowledge Scale.
The scale consists of 5 items, with total scores ranging from 0 to 5. Higher scores indicate a higher level of diabetic foot care knowledge.
Change in scores from baseline to the end of the 4-week intervention period will be evaluated.
|
Baseline and at the end of Week 4
|
|
Change in Diabetic Foot Self-Care Behavior
Tidsramme: Baseline and at the end of Week 4
|
Diabetic foot self-care behavior will be assessed using the Diabetic Foot Self-Care Behavior Scale.
The scale consists of 7 items, with total scores ranging from 7 to 35.
Higher scores indicate better diabetic foot self-care behavior.
Change in scores from baseline to the end of Week 4 will be evaluated.
|
Baseline and at the end of Week 4
|
|
Change in Diabetic Foot Care Self-Efficacy
Tidsramme: Baseline and at the end of Week 4
|
Diabetic foot care self-efficacy will be assessed using the Diabetic Foot Care Self-Efficacy Scale.
The scale consists of 9 items rated from 0 (not at all confident) to 10 (very confident).
Higher scores indicate greater diabetic foot care self-efficacy.
Change in scores from baseline to the end of Week 4 will be evaluated.
|
Baseline and at the end of Week 4
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Zeliha Büyükbayram Genç, PhD, Siirt University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
20. september 2026
Primær færdiggørelse (Anslået)
15. juli 2027
Studieafslutning (Anslået)
31. juli 2027
Datoer for studieregistrering
Først indsendt
4. september 2026
Først indsendt, der opfyldte QC-kriterier
4. september 2026
Først opslået (Faktiske)
10. september 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
10. september 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
4. september 2026
Sidst verificeret
1. september 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Sygdomme i det endokrine system
- Karsygdomme
- Hjerte-kar-sygdomme
- Metaboliske sygdomme
- Glukosemetabolismeforstyrrelser
- Diabetes mellitus
- Diabetiske angiopatier
- Diabetes komplikationer
- Hudsygdomme
- Hudsår
- Bensår
- Diabetiske neuropatier
- Fodsår
- Ernæringsmæssige og metaboliske sygdomme
- Hud- og bindevævssygdomme
- Diabetes mellitus, type 2
- Diabetisk fod
Andre undersøgelses-id-numre
- 2026-SİÜSBF-016 (Andet bevillings-/finansieringsnummer: Siirt University Scientific Research Projects Coordination Unit)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .